News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Arndt Vogel Highlighted Phase II PANACHE01 Trial on Neoadjuvant FOLF(IRIN)OX for Resectable PDAC
Arndt Vogel/X
Jun 8, 2025, 16:48

Arndt Vogel Highlighted Phase II PANACHE01 Trial on Neoadjuvant FOLF(IRIN)OX for Resectable PDAC

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School, shared a post on X:

“Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable PDAC, published in JCO.
Phs II Trial PANACHE01 FRENCH08 PRODIGE48 study
– mFOLFIRINOX feasible
– supports ongoing trials such as PREOPANC3, Alliance AO21806″

PANACHE01

Title: Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)

Journal: JCO

Authors: Lilian Schwarz, Jean-Baptiste Bachet, Aurelia Meurisse, Olivier Bouché, Eric Assenat, Guillaume Piessen, Pascal Hammel, Nicolas Regenet, Julien Taieb, Olivier Turrini, Francois Paye, Anthony Turpin, Francois-Regis Souche, Christophe Laurent, Reza Kianmanesh, Pierre Michel, Dewi Vernerey, Jean-Yves Mabrut, Celia Turco, Stephanie Truant, Antonio Sa Cunha

Read the full article.

PANACHE01

More posts featuring Arndt Vogel on OncoDaily.

Anthony Turpin Antonio Sa Cunha Arndt Vogel ASCO Aurelia Meurisse cancer Celia Turco Christophe Laurent Dewi Vernerey Eric Assenat Francois Paye Francois-Regis Souche FRENCH08 Guillaume Piessen Hannover Medical School JCO Jean-Baptiste Bachet Jean-Yves Mabrut Julien Taieb Lilian Schwarz mFOLFIRINOX Nicolas Regenet Olivier Bouché Olivier Turrini OncoDaily Oncology PANACHE01 pancreatic adenocarcinoma Pascal Hammel PDAC Pierre Michel PREOPANC3 PRODIGE48 Reza Kianmanesh Stephanie Truant
Special Coverage
Blog
Jun 29, 2025, 12:01
Hanan Elgamal: Proud to Have Joined Ahmad Morsy to Represent Gustave Roussy at Africa Health ExCon 2025
Blog
Jun 29, 2025, 11:48
Mounir Bachouchi Highlighted MoASCC Presence at MASCC 2025 and Future Goals for Morocco
Blog
Jun 29, 2025, 11:33
Don Dizon: An Amazing 2 Days with Drs Anne Katz and Linda Bosserman at MASCC 2025
Blog
Jun 29, 2025, 11:21
MASCC Thanks 2025 Social Media Ambassadors for Contributions During Annual Meeting
Science
Jun 29, 2025, 11:09
Myeloma Paper of the Day, June 29th, Suggested by Robert Orlowski
Blog
Jun 29, 2025, 11:06
Aditi Bhatt Shared Study on Challenges of Surgical Intervenions in Occult Peritoneal Spaces
Blog
Jun 29, 2025, 10:44
Flavio Rocha Welcomes the Cholangiocarcinoma Foundation Community to OHSU for Regional Symposium
Blog
Jun 29, 2025, 10:35
Elvina Almuradova: Could Breast Cancer Treatments Impact Alzheimer’s risk?
Blog
Jun 29, 2025, 10:32
Darcy Burbage Shares Insights on Peer Navigation in Cancer Care at MASCC25
Blog
Jun 29, 2025, 10:22
Society for Integrative Oncology is Excited to Welcome Dr. Judson Brewer - as Tuesday’s Keynote Speaker!
Insight
Jun 29, 2025, 10:20
Azin Alizadehasl Shared New Book on Cardiovascular Interventions Published by Springer
Blog
Jun 29, 2025, 09:56
Debate Session of the 9th Cohort of the Policy Advocacy in Genetics and Genomics Course by PAPERI